A laboratory partnership can involve several different services: testing a patient’s sample, interpreting a result, storing specimens, or making data available for research. Bundling them into one proposal can hide important differences in oversight and responsibility.
Before comparing vendors, write down which decisions the service will support. A research repository and a laboratory producing patient-care results need different workflows, even when they handle the same type of sample.
Clarify clinical testing versus research
CMS guidance on CLIA explains that testing human specimens for health assessment, diagnosis, prevention, or treatment generally requires an appropriate CLIA certificate. Research-only exceptions depend on what the laboratory does with patient-specific results. Calling a project “research” does not resolve the question by itself.
Request the laboratory’s current certificates, test menu, and the identity of any subcontracting laboratory. If accreditation is part of the proposal, verify its scope. Ask the vendor to distinguish laboratory certification from evidence supporting a particular clinical interpretation.
Examine the report a clinician will receive
Have the clinical team review a representative report before contracting. It should make the tested variants, limitations, and basis for interpretation understandable. A pharmacogenomic result is one input to care; it does not replace consideration of the patient’s condition, other medicines, and relevant clinical guidance.
Ask what happens when evidence changes. Will old reports be amended, will clinicians receive a notice, and is that service included? Agree on who answers questions when a result is unclear or a sample fails quality checks.
Follow a specimen through the entire process
Map collection, labeling, transport, accessioning, processing, storage, retrieval, and disposal. Request an explanation of how the system prevents identity mismatches and records exceptions. For stored samples, specify temperature monitoring, backup capacity, incident notification, and inventory reconciliation.
A useful vendor exercise is to trace one fictional specimen from collection to release. Include a delayed shipment and a storage alarm. The response should identify who acts, what gets documented, and when the customer is notified.
Make research permissions explicit
Specimen consent, research oversight, and privacy authorization are related but separate issues. HHS guidance on research uses and disclosures explains authorization and permitted waiver pathways for covered entities. Do not assume that consent to clinical testing permits every future research use.
Specify permitted access, secondary use, data retention, subcontracting, and disposition when the agreement ends. Have the appropriate privacy and research teams review proposed sharing arrangements before samples or data move.
Compare total operating cost
- Initial testing and repeat testing after sample failure.
- Storage, retrieval, shipping, and destruction charges.
- Electronic health record integration and support.
- Data export, contract termination, and repository transfer.
The best contract makes the boundaries visible. Clinical staff should know what the result can support, researchers should know what use is permitted, and operations staff should know how to recover service after a disruption.